| 1 |
32894831 | Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro Study. | 2021 |
1 |
| 2 |
33610598 | Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents. | 2021 Apr 15 |
1 |
| 3 |
33968948 | The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19. | 2021 |
1 |
| 4 |
34596979 | Elucidating the Binding Mode between Heparin and Inflammatory Cytokines by Molecular Modeling. | 2021 Oct |
1 |
| 5 |
34639073 | Molecular Mechanism of the Anti-Inflammatory Action of Heparin. | 2021 Oct 3 |
2 |
| 6 |
32289862 | Heparanase Facilitates PMA-Induced Megakaryocytic Differentiation in K562 Cells via Interleukin 6/STAT3 Pathway. | 2020 Apr |
2 |
| 7 |
32469940 | Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. | 2020 |
4 |
| 8 |
30016181 | Unfractionated Heparin Modulates Lipopolysaccharide-Induced Cytokine Production by Different Signaling Pathways in THP-1 Cells. | 2018 Jul |
1 |
| 9 |
28486961 | Role of heparin in pulmonary cell populations in an in-vitro model of acute lung injury. | 2017 May 10 |
2 |
| 10 |
27011369 | The presence of heparins during decidualization modulates the response of human endometrial stromal cells to IL-1β in vitro. | 2016 Jul |
3 |
| 11 |
27196743 | Delivery of the high-mobility group box 1 box A peptide using heparin in the acute lung injury animal models. | 2016 Jul 28 |
2 |
| 12 |
27599556 | Heparin inhibits the inflammation and proliferation of human rheumatoid arthritis fibroblast‑like synoviocytes through the NF‑κB pathway. | 2016 Oct |
1 |
| 13 |
25454806 | Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K/Akt/NF-κB signaling pathway in human endothelial cells. | 2015 Mar |
1 |
| 14 |
26280503 | Optimized Treatment of Heparinized Blood Fractions to Make Them Suitable for Analysis. | 2015 Aug |
1 |
| 15 |
24287143 | Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitis. | 2014 Feb |
1 |
| 16 |
25237354 | Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial. | 2014 Spring |
1 |
| 17 |
24273488 | Promoting Effects of Heparin on ex vivo Expansion of Megakaryocytopoiesis from Human Cord Blood CD34+ Cells. | 2013 Oct |
1 |
| 18 |
20132164 | Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity. | 2010 May |
1 |
| 19 |
18327406 | Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood. | 2008 Mar |
1 |
| 20 |
19114189 | Formation of anti-platelet factor 4/heparin antibodies after cardiac surgery: influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status. | 2008 Dec |
1 |
| 21 |
18070750 | Adipocyte-derived lipoprotein lipase induces macrophage activation and monocyte adhesion: role of fatty acids. | 2007 Nov |
1 |
| 22 |
15282657 | Role of anti-PF4/heparin antibodies in recurrent thrombotic events after acute coronary syndromes. | 2004 Jun |
1 |
| 23 |
15815878 | Antibodies to platelet factor 4/heparin are associated with elevated endothelial cell activation markers in patients with acute coronary ischemic syndromes. | 2004 Dec |
1 |
| 24 |
11920660 | Heparin-like polymers modulate proinflammatory cytokine production by lipopolysaccharide-stimulated human monocytes. | 2002 Jun 5 |
1 |
| 25 |
11971193 | Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. | 2002 Apr 11 |
1 |
| 26 |
11694151 | Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. | 2001 Nov 7 |
1 |
| 27 |
11770031 | Modulating IL-6 and IL-10 levels by pharmacologic strategies and the impact of different extracorporeal circulation parameters during cardiac surgery. | 2001 |
1 |
| 28 |
11820460 | Influence of low molecular weight heparin (certoparin) and unfractionated heparin on the release of cytokines from human leukocytes. | 2001 Oct |
1 |
| 29 |
12536495 | [Influence of low-molecular weight heparin on urine interleukin-6 in patients with proliferative glomerulonephritis]. | 2001 Oct 28 |
3 |
| 30 |
10816058 | Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. | 2000 |
1 |
| 31 |
10832659 | Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations. | 2000 Apr |
2 |
| 32 |
11067924 | Characterization of the heparin-binding properties of IL-6. | 2000 Nov 15 |
7 |
| 33 |
12501620 | [The effect of heparin on mesangial cells proliferation and cytokines production]. | 2000 Mar |
4 |
| 34 |
10363611 | Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. | 1999 Apr |
2 |
| 35 |
10658376 | Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass. | 1999 Dec |
1 |
| 36 |
9704387 | Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation. | 1998 |
1 |
| 37 |
9212969 | Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass. | 1997 Jul |
1 |
| 38 |
8838671 | Glycosaminoglycans modulate cell-matrix interactions of human fibroblasts and endothelial cells in vitro. | 1996 Feb |
1 |
| 39 |
7677475 | Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. | 1995 Sep |
3 |
| 40 |
7998663 | Augmented interleukin-6 secretion in collagen-stimulated peripheral blood mononuclear cells from patients with systemic sclerosis. | 1994 Dec |
1 |
| 41 |
3966907 | Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture. | 1985 Jan-Feb |
1 |